Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1232 to 1281 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hect domain containing protein 1 (fragment). [source:swissprot;acc:q9ult8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2569\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3964.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4042.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01968\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hect type e3 ubiquitin ligase. [source:refseq;acc:nm\_015052]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1148\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6281.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6837.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
helicase (fragment). [source:sptrembl;acc:q92771]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2498\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7002.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7191.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02711\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
785\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4997\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5557.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase 2. [source:refseq;acc:nm\_147174]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2202\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5076.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5326.29\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.04916\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase; heparan-sulfate 6-sulfotransferase. [source:refseq;acc:nm\_004807]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2203\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl  3-o-sulfotransferase 2; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006043]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2424\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7355.46\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7088.93\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0376\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3a1; heparin-glucosamine 3-o-sulfotransferase. [source:refseq;acc:nm\_006042]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2422\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
heparan sulfate d-glucosaminyl 3-o-sulfotransferase 3b1. [source:refseq;acc:nm\_006041]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2423\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heparan sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.8) (n-hsst) (hsnst) ([heparan sulfate]-glucosamine n-sulfotransferase) (n-heparan sulfate sulfotransferase) (glucosaminyl n-deacetylase/n- sulfotransferase). [source:swissprot;acc:p52848]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
859\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5210.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5749.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1034\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
heparin sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.-) (n- hsst) (n-heparin sulfate sulfotransferase) (glucosaminyl n- deacetylase/n-sulfotransferase). [source:swissprot;acc:p52849]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
856\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatitis c virus core-binding protein 6; cervical cancer oncogene 3. [source:refseq;acc:nm\_023934]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1907\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6858.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7287.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocellular carcinoma susceptibility protein; x 003 protein; hdcmc29p; hspc260; likely ortholog of mouse cd40 ligand-activated specific transcript 3 (clast3). [source:refseq;acc:nm\_020232]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2329\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
157\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
18263\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca3. [source:refseq;acc:nm\_138703]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
153\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocyte growth factor-regulated tyrosine kinase substrate; human growth factor-regulated tyrosine kinase substrate. [source:refseq;acc:nm\_004712]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1932\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10300\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9701.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06171\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-alpha (hnf-3a) (forkhead box protein a1). [source:swissprot;acc:p55317]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1479\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5787.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6221.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07511\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-beta (hnf-3b) (forkhead box protein a2). [source:swissprot;acc:q9y261]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1499\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5798.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6230.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocyte nuclear factor 3-gamma (hnf-3g) (forkhead box protein a3) (fork head-related protein fkh h3). [source:swissprot;acc:p55318]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1401\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5728.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6175.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07804\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-alpha (hnf-4-alpha) (transcription factor hnf-4) (transcription factor 14). [source:swissprot;acc:p41235]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2494\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3436.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3531.96\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02773\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-gamma (hnf-4-gamma). [source:swissprot;acc:q14541]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2491\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hepatoma-derived growth factor (hdgf) (high-mobility group protein 1- like 2) (hmg-1l2). [source:swissprot;acc:p51858]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
387\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4533.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5279.4\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16447\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
hepatoma-derived growth factor-related protein 2. [source:refseq;acc:nm\_032631]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
383\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a1 (helix-destabilizing protein) (single-strand binding protein) (hnrnp core protein a1). [source:swissprot;acc:p09651]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3) (d10s102). [source:swissprot;acc:p51991]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1818\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein f (hnrnp f). [source:swissprot;acc:p52597]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1397\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.23\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07805\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h (hnrnp h). [source:swissprot;acc:p31943]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1398\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.05\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h' (hnrnp h') (ftp-3). [source:swissprot;acc:p55795]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1399\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.03\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein h3 (hnrnp h3) (hnrnp 2h9). [source:swissprot;acc:p31942]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1400\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.43\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein k (hnrnp k) (dc-stretch binding protein) (csbp) (transformation upregulated nuclear protein) (tunp). [source:swissprot;acc:q07244]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2488\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5637.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5804.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0296\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein l (hnrnp l). [source:swissprot;acc:p14866]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
895\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10247.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein m (hnrnp m). [source:swissprot;acc:p52272]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2699\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5356.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5378.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
185\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4069.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5252.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29051\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoproteins a2/b1 (hnrnp a2 / hnrnp b1). [source:swissprot;acc:p22626]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1828\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
heterogenous nuclear ribonucleoprotein u (hnrnp u) (scaffold attachment factor a) (saf-a). [source:swissprot;acc:q00839]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2691\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4113.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4095.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00446\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hexaprenyldihydroxybenzoate methyltransferase, mitochondrial precursor (ec 2.1.1.114) (dihydroxyhexaprenylbenzoate methyltransferase) (3,4- dihydroxy-5-hexaprenylbenzoate methyltransferase) (dhhb methyltransferase) (dhhb-mt) (dhhb-mtase). [source:swissprot;acc:q9nzj6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1506\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6152.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6610.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
high mobility group protein 1 (hmg-1). [source:swissprot;acc:p09429]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2989\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
high mobility group protein 1-like 10 (hmg-1l10). [source:swissprot;acc:q9ugv6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3144\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
high mobility group protein 2 (hmg-2). [source:swissprot;acc:p26583]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2856\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
high mobility group protein 4 (hmg-4) (high mobility group protein 2a) (hmg-2a). [source:swissprot;acc:o15347]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3203\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
high mobility group protein 4-like (hmg-4l). [source:swissprot;acc:q9uj13]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2787\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
high-affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a (ec 3.1.4.17). [source:swissprot;acc:o76083]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2876\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
high-glucose-regulated protein 8 (ny-ren-2 antigen). [source:swissprot;acc:q9y5a9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2863\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
high-mobility group 20a. [source:refseq;acc:nm\_018200]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
122\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5140.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6893.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.34112\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
high-mobility group 20b; sox-like transcriptional factor; swi/snf-related matrix-associated actin-dependent regulator of chromatin subfamily e, member 1-related. [source:refseq;acc:nm\_006339]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
120\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5136.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6895.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.34247\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
highly expressed in cancer, rich in leucine heptad repeats. [source:refseq;acc:nm\_006101]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2631\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4508.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4446.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01403\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
hira-interacting protein 5 (cgi-33). [source:swissprot;acc:q9ums0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12471.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14561.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16758\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
histidine ammonia-lyase (ec 4.3.1.3) (histidase). [source:swissprot;acc:p42357]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1382\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07829\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
699\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7101.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7949.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11939\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
histidine-rich membrane protein ke4. [source:swissprot;acc:q92504]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1743\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6298.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6722.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06729\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/